1. To review the diagnosis of gout and its differential. 2. To understand the four stages of gout
|
|
- Holly Hunter
- 6 years ago
- Views:
Transcription
1 Objectives 1. To review the diagnosis of gout and its differential GOUT 2. To understand the four stages of gout 3. To develop an approach for the acute treatment of gout Anthony Lim 9/13/12 Cycle 3 4. To recognize when a pt should start ppx for gout and how to go about it Epidemiology ~ 3.9 million office visits per year Affects ~ 5% all men over age 65 Prevalence slowly increasing (obesity, aging population, diuretic-treated HTN) 90% pts men > 30 (peak age 40 60) More common in African-Americans Quality of rx suboptimal in up to ½ of pts Pathophysiology Risk Factors Any systemic factor that increases risk of hyperuricemia: High purine diet High levels meat and seafood, esp internal organs Dairy products: opposite effect EtOH use 12-year prospective study of ~ 50k males w/o gout > = 2 beers: 2.5x RR Beers > Spirits (1.6x) Wine not associated w/ increased risk Sugar-sweetened beverages/foods Obesity Diuretic Therapy Thiazides = Loop diuretics (RR 1.77) 1
2 Common Triggers for acute flares Infection IV contrast media Rapid fluctuations in [uric acid] Trauma Surgery Starvation Chemotherapy initiation Diuretic therapy (loop, thiazide) Diet/EtOH consumption Four Stages of Gout 1. Asymptomatic Hyperuricemia 2. Acute Gouty Arthritis 3. Interval Gout 4. Chronic Tophaceous Gout Stage 1: Asx Hyperuricemia Common and typically does not lead to gout Serum Uric Acid Level (mg/dl) % Greater than 9 4.5% Annual incidence of gout Stage 2: Acute Gouty Arthritis Initial attack often involves single LE joint First MTP (75%) > midtarsal, ankle, knee Polyarticular: < 20% Sudden onset exquisite pain Peaks w/in 24 48h Erythema, swelling, tenderness, warmth Occasionally accompanied by fever Typically lasts 5 7 days ACR: 6 of 12 criteria (e.g., monoarticular, pain, swelling, redness, < 24h, first MTP joint) Definitive Diagnosis Work-Up MSU crystals in synovial fluid Polarized microscopy, the crystals appear as bright negatively birefringent yellow crystals Se: 85%; Sp: 100% Joint Aspiration Serum Uric Acid X-ray should be measured two weeks or more after complete resolution of an acute gout flare both for accuracy and for establishing a baseline value. Often not necessary with initial attack 2
3 DDx Stage 3: Interval Gout Trauma Septic Arthritis (knee, + gram stain/cx, leukocytosis, fever. Defer steroid injection) Gonococcal arthritis (fever, rash, gonorrhea) Rheumatoid Arthritis (b/l, symmetric) Pseudogout (+ birefringence, rarer) Asx period after initial attack May last for years 60% have recurrence w/in 1y, 75% w/in 2y < 10% never have repeat bout Subsequent attacks Often polyarticular increased severity OA (Arthralgia/non-inflammatory, weight-bearing joints) Stage 4: Chronic Tophaceous Gout Occurs in pts w/ poorly controlled gout > 10-20y Tophi Seen only after several attacks Cause deformity & destruction of hard & soft tissue Common locations: extensor surface of forearms, elbows, knees, achilles tendons, pinna of external ear Renal Complications: Nephrolithiasis Chronic urate nephropathy Treatment Objectives 1. Symptom Control for acute attacks 2. Risk Factor modification 3. Prevention of recurrence 4. Preventing chronic sequelae (renal stones, tophi, destructive arthropathy) Non-Pharmacologic Rx Acute Treatment: Options Ice packs EtOH abstinence Dietary Modification Less red meat and seafood Avoid sweetbreads More dairy Weight loss 1. NSAIDs 2. Corticosteroids 3. Colchicine 4. Intra-articular Injections Substitution of diuretic therapy w/ other antihypertensives 3
4 Acute Treatment: NSAIDs Acute Treatment: Corticosteroids 1 st line No NSAID found to work better than others ASA avoided Regimens (~ 7 days): Indocin 50 mg po tid Naproxen 500 mg bid Ibuprofen 800 mg tid Consider dose reductions once sx s have improved Pts who cannot tolerate NSAIDs Improvement typically seen in 12-24h Dosing: Generally: mg/day x 3-5 days, then taper over 1 2 weeks Sample regimen: Ten days total 50 x 2, 40 x 2, 30 x 2, 20 x 2, 10 x 2 Acute Treatment: Injection Intra-articular injection w/ steroids Indication: Cannot tolerate NSAIDs Idealy only one affected joint Acute Treatment: Colchicine Second-line therapy Impairs neutrophil motility and activity Initial dose: 1.2 mg, 1 hr later 0.6 mg Subsequent Dosing: 0.6 mg bid Best if used w/in 1 st 24h of attack Common s/e: N/V/D Prophylaxis: Indications 1. > 2 attacks per year 2. Tophi 3. Joint damage by radiograph 4
5 Prophylaxis: Steps Allopurinol Mechanism 1. Start once acute phase of gout has completely resolved Fluctuations in [uric acid] worsens inflammation 2. Start w/ low dose Allopurinol (100 mg) Titrate up by 100 mg every 2 weeks until [uric acid] < 6 mg/dl (max dose: 800 mg) 2-5% minor rash Severe Hypersensitivity Syndrome (rare): fever, toxic epidermal necrolysis, hepatitis, eosinophilia 3. Administer concurrent ppx w/ low-dose colchicine (0.6 mg bid x 3-6m) reduces risk of flare-ups Prophylaxis: Probenecid Probenecid Mechanism Second-line therapy Sometimes combined w/ allopurinol for refractory hyperuricemia Uricosuric: Increase renal clearance of uric acid by inhibiting tubular absorption S/e: GI & kidney stones Prophylaxis: Other Agents Losartan & Fenofibrate (Tricor) Potentially useful adjunct rx for pts w/ gout, HTN, and HL Vitamin C Double-blinded placebo-controlled randomized trial 184 nonsmokers 500 mg/day Vitamin C vs placebo x 2 months Vit C group: significant mean decrease [uric acid] of 0.5 mg/dl 5
6 True 6
7 Take-Home Points Synovial fluid MSU crystals provides definitive dx of gout Keep in mind the four stages of gout when evaluating a patient for gout For acute gout, NSAIDs = first line acute treatment. Steroids and Colchicine are second-line. PPx generally achieved via Allopurinol titration to serum uric acid < 6, along w/ colchicine initially to prevent acute flare THANKS!! References Becker MA. Clinical Manifestations and Diagnosis of Gout. UpToDate Becker MA. Treatment of Acute Gout. UpToDate Becker MA. Prevention of Recurrent Gout. UpToDate Pittman, JR, Bross, MH. Diagnosis and Management of Gout. American Family Physician 1999;59. Eggebeen AT. Gout: An Update. American Family Physician 2007; 76:801-8). 7
Gout -revisited. Shrenik Shah
Gout -revisited Shrenik Shah definition Monosodium urate (MSU) crystal deposition episodic and later persistent joint inflammation and tophi All MSU crystal deposition- broader definition EULAR- European
More informationCrystal induced arthropathies. Dr. Amitesh Aggarwal
Crystal induced arthropathies Dr. Amitesh Aggarwal 1 Crystal induced Arthropathies Gout Pseudogout Debilitating illnesses; Recurrent episodes of pain and joint inflammation; Formation and deposition of
More informationEnhanced Primary Care Pathway: Gout
Enhanced Primary Care Pathway: Gout 1. Focused summary of gout relevant to primary care Significance: Gout is a chronic, progressive, inflammatory disease requiring appropriate long-term management. Gout
More informationGout 2.0. Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy
Gout 2.0 Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy Case 48 year old man presents with swollen, painful left toe that started overnight. Didn t hurt when he went to bed. No
More informationGout Treatment Guidelines
Gout Treatment Guidelines Gout is a disorder that manifests as a spectrum of clinical and pathologic features built on a foundation of an excess body burden of uric acid, manifested in part by hyperuricemia,
More informationRheumatoid arthritis, seronegative spondylarthritides and gout. György Nagy
Rheumatoid arthritis, seronegative spondylarthritides and gout György Nagy Dec 4, 2017 Rheumatoid arthritis Rheumatoid arthritis Chronic, progressive, autoimmune disorder of the joints with extra-articular
More informationGOUT IN THE ELDERLY. Learning Objectives. Disclosure. Geriatric Grand Rounds. Geriatric Grand Rounds
Visit web sites: Tuesday, June 2, 2009 12:00 noon Dr. Bill Black Auditorium Glenrose Rehabilitation Hospital In keeping with Glenrose Rehabilitation Hospital policy, speakers participating in this event
More informationOBJECTIVES GOUT GOUTY INFLAMMATION 6/10/2016 GOUT INCIDENCE AND PREVALENCE MONOSODIUM URATE CRYSTAL DEPOSITION DISEASE
GOUT Lisa Talbert, MD Family Medicine Update June 15, 2016 OBJECTIVES To be familiar with the clinical presentation and pathophysiology of gouty arthritis Be able to incorporate current guidelines when
More informationGout: Develop treatment plan in William Jones, MS, RPh
Gout: Develop treatment plan in 2013 William Jones, MS, RPh (wnjones49@cox.net) Objectives Describe acute gouty arthritis Tx Describe Tx of chronic gouty arthritis. Define the target serum uric acid concentration
More informationGOUT. Dr Krishnan Baburaj West herts NHS Trust
GOUT Dr Krishnan Baburaj West herts NHS Trust podagra Gout A disease of kings, the king of diseases History Louis XIV Emperor Augustus Henry VIII Introduction Gout an inflammatory arthritic condition that
More informationCHAPTER:2 GOUT. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:2 GOUT BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY DEFINITION Gout is defined as a peripheral arthritis, resulting from the deposition of MSU crystals
More informationLecture 8 Gout Hinch. Pathogenesis of acute attacks
Gout: disease characterized by deposition of monosodium crystals in soft tissues (cartilage, tendons, bursa) recurrent episodes of acute joint pain & inflammation Pathogenesis of acute attacks Epidemiology:
More informationCase presentation. serum uric acid = 11.5 mg/dl 24-hour uric acid excretion = 300 mg
GOUT 55 y/o male 12 hours pain in my big toe & ankle went to bed last night feeling fine felt as if had broken toe this morning similar problems in right ankle & left wrist Case presentation lab studies
More informationGout A rapid review. Jeremy Jones
Gout A rapid review Jeremy Jones The Hyperuricemia Cascade Dietary purines Tissue nucleic acids Urate Endogenous purine synthesis Overproduction Hyperuricemia Underexcretion Silent tissue deposition Gout
More informationA Patient s Guide to Gout. Foot and Ankle Center of Massachusetts, P.C.
A Patient s Guide to Gout Welcome to Foot and Ankle Center of Massachusetts, where we believe in accelerating your learning curve with educational materials that are clearly written and professionally
More informationPodcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam. Howard J. Sachs, MD
Podcast (Video Recorded Lecture Series): Gout for the USMLE Step One Exam Howard J. Sachs, MD www.12daysinmarch.com Email: Howard@12daysinmarch.com Podcast (Video Recorded Lecture Series): Gout for the
More informationGout. Clinical features Most commonly affects middle-aged males. It is an acute and usually relapsing selflimiting
Gout Gout is a syndrome caused by an inflammatory response to the formation of monosodium urate monohydrate crystals which develop secondary to hyperuricemia. Acute and chronic forms are recognized. Hyperuricemia
More informationUpdate on Gout for GPs
Update on Gout for GPs Dr Patrick Kiely PhD FRCP Consultant Physician and Rheumatologist St George s, London 2/3 1/3 Gut bacteria have uricase Chronic erosive arthropathy Clinical spectrum Making the diagnosis
More informationGOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R.
GOUT & PSEUDOGOUT OPSC 2018 HOWARD L. FEINBERG, D.O., F.A.C.O.I.., F.A.C.R. Everything in excess is opposed by nature Eunuchs do not take the gout, nor become bald. GOUT Hyperuricemia is not gout Gout
More informationPennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016
Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Gout and Pseudogout Wayne Blount MD Speaker has no disclosures
More informationRheumatology Cases for the Internist
Rheumatology Cases for the Internist Marc C. Hochberg, MD, MPH Professor of Medicine Head, Division of Rheumatology and Clinical Immunology Vice Chair, Department of Medicine University of Maryland School
More informationGout- Treatment Updates. Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA
Gout- Treatment Updates Harinder Singh, MD Rheumatology Mercy Internal Medicine Clinic Mason City, IA Gout Outline of purine metabolism: (1) amidophosphoribosyltransferase (2) hypoxanthine-guanine phosphoribosyltransferase
More informationManaging Gout A Review of the Research for Adults
Managing Gout A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional* has said that you have gout. You are age 18 or
More informationCrystal-Induced Arthritis. Rajesh Kataria, D.O. Southern Ohio Rheumatology
Crystal-Induced Arthritis Rajesh Kataria, D.O. Southern Ohio Rheumatology Disclosures Speaker: Rajesh Kataria, D.O. Relationships with commercial interests: Speakers Bureau - Horizon Presentation will
More informationGout: Update in therapeutics
Summary Gout: Update in therapeutics 29/11/14 Caroline van Durme CHU de Liège Maastricht University Medical Centre+ Why treating gout? Guidelines: ACR 12 Drugs: Colchicine Allopurinol: what about the kidney?
More informationRHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center
RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases
More informationGout: Let s Be Crystal Clear. Dr. Philip A. Baer Seacourses Asia CME December 2017
Gout: Let s Be Crystal Clear Dr. Philip A. Baer Seacourses Asia CME December 2017 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or
More informationGout Hanan Abdel Rehim
Review article 35 Gout Hanan Abdel Rehim Department of Internal Medicine, Kasr-Al Aini School of Medicine, Cairo University, Cairo, Egypt Correspondence to Hanan Abdel Rehim, MD, 11 Ismaiel Wahby Street,
More informationWhat will happen in the future? How will gout be diagnosed? How is gout treated? prevent
Rheumatology Day Unit Dr J Hamilton 0191 4458359 0191 4455240 (9-5 Mon-Fri) Dr C Heycock 0191 4452198 Answer phone on 24hours Dr C Kelly 0191 4452193 Dr V Saravanan 0191 4456055 Dr M Rynne 0191 4458359
More informationuric acid Non electrolytes of the plasma
73 uric acid Non electrolytes of the plasma 1 Purines and uric acid Fig 2 JFI Uric acid is the major product of catabolism of the purine nucleosides adenosine and guanosine, Uric acid is sparingly soluble
More informationMono-articular Joint Complaints
Mono-articular Joint Complaints Derrick J. Todd, M.D., Ph.D. Associate Physician Department of Rheumatology, Immunology, and Allergy Brigham and Women s Hospital Instructor of Medicine Harvard Medical
More informationAn update on the management of gout
An update on the management of gout 8 The management of gout involves treatment of an acute attack, lifestyle modification and urate lowering treatment to achieve a target serum urate level. Recent evidence
More informationLECTURE 5: DRUGS IN GOUT
Red : important Black : in male / female slides Pink : in female s slides only Blue : in male s slides only Green : Dr s notes Grey: Extra information, explanation Editing File LECTURE 5: DRUGS IN GOUT
More informationGout basics. Update on Gout. Production of uric acid. Gout basics. Crystal induced inflammation. Gout calculator. The important role of ultrasound
Update on Gout The important role of ultrasound Cheung C Yue, M.D. Gout basics Hyperuricemia gout Over 5 years, 22% >9 mg/dl develop gout Man 3-4 times more than women Risks: thiazide, cyclosporin, low
More informationDrugs Used to Treat Gout. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Drugs Used to Treat Gout Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Gout is a metabolic disease characterized by recurrent episodes of acute arthritis
More informationAchieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP
Achieving Gout Goals in Your Practice An Interview with Paul P. Doghramji, MD, FAAFP Dr. Paul Doghramji is attending physician at the Pottstown Memorial Medical Center and medical director of Health Services
More informationFor more information about how to cite these materials visit
Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationAcute hot swollen joint. Dr Edward Roddy Senior Lecturer in Rheumatology and Consultant Rheumatologist
Acute hot swollen joint Dr Edward Roddy Senior Lecturer in Rheumatology and Consultant Rheumatologist Acute monoarthritis: differential diagnosis Septic arthritis Crystal arthritis (gout, pseudogout) Haemarthrosis
More information4/1/2011. New Developments in Gout. Conflict of Interest Declaration. Objectives
New Developments in Gout Tatum N. Mead, Pharm.D. Clinical Assistant Professor UMKC SOP meadt@umkc.edu April 16, 2011 1 Conflict of Interest Declaration I have no actual or potential conflict of interest
More informationPART MUSCULOSKELETAL DISORDERS
PART 12 MUSCULOSKELETAL DISORDERS CASE STUDY 77 GOUT For the Patient Case for this case study, see the printed book. DISEASE SUMMARY Definitions Gout is a syndrome of abnormal purine (i.e., DNA nucleotide
More informationGOUT GO FOR SIX WITH. Everything You Need to Know About Gout & Uric Acid PLUS:
GO FOR SIX WITH Everything You Need to Know About Gout & Uric Acid GOUT PLUS: How to gain control of symptoms A gout-friendly eating style Medication recommendations to discuss with your doctor Lifestyle
More informationGout. Crystal deposition disease: Imaging perspectives. Crystal associated arthropathies. Clinical Stages of Gout 07/06/60
Crystal associated arthropathies Crystal deposition disease: Imaging perspectives Warapat Virayavanich, MD Ramathibodi hospital, Mahidol University Commonly seen arthropathy MSU (gout) CPPD HADD Uncommon
More information3/2/2014. Got Gout? Get a Plumber. Objectives. Disclosures
Got Gout? Get a Plumber. Heidi Garcia, PA-C Department of Rheumatology Division of Internal Medicine Mayo Clinic Arizona 2013 MFMER slide-1 Objectives Recall some of the history of Gout. Describe the pathophysiology
More informationKeeping up with Arthritis
Keeping up with Arthritis Carlin Senter, MD July 6, 2015 UCSF Essentials of Women s Health I have nothing to disclose Objectives At the end of this lecture you will know 1. The differential diagnosis for
More informationDose of celecoxib in gout attack attack
Dose of celecoxib in gout attack Gout is a disease characterized by an abnormal metabolism of uric acid, resulting in an excess of uric acid in the tissues and blood. People with gout either produce too
More informationSubject: Krystexxa (pegloticase) Original Effective Date: 06/26/13. Policy Number: MCP-138. Revision Date(s):
Subject: Krystexxa (pegloticase) Original Effective Date: 06/26/13 Policy Number: MCP-138 Revision Date(s): Review Date(s): 12/16/15; 6/15/2016; 3/21/2017 DISCLAIMER This Molina Clinical Policy (MCP) is
More informationInitial Phase 3 Studies Results for Rilonacept in the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapy and the Treatment
Initial Phase 3 Studies Results for Rilonacept in the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapy and the Treatment of Patients in the Midst of an Acute Gout Attack Investor
More informationGout FACTSHEET REAL LIFE STORY
1 What is gout? Gout is a type of arthritis where swelling and severe pain develops rapidly in joints, especially at the base of the big toe. Gout affects approximately one in 30 adults, most commonly
More informationUrate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout
Philippine Journal of Internal Medicine Meta-Analysis Urate Lowering Efficacy of Febuxostat Versus Allopurinol in Hyperuricemic Patients with Gout Erika Bianca S. Villazor-Isidro, M.D.*; John Carlo G.
More informationEtiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis
Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may
More informationPlus: How to gain control of symptoms A gout-friendly eating style Lifestyle changes that can help prevent future attacks
about Gout What You Need to Know about Gout & Uric Acid Plus: How to gain control of symptoms A gout-friendly eating style Lifestyle changes that can help prevent future attacks We re doing everything
More informationDisclosures. Goals. Rheumatology Review for Primary Care. No commercial disclosures. We will be discussing non-fda approved uses for some medications.
Rheumatology Review for Primary Care April 27, 2018 MONA Coming Together in Advanced Practice Disclosures No commercial disclosures. We will be discussing non-fda approved uses for some medications. Goals
More informationCOPYRIGHT. Update in Internal Medicine December 4, 2016
Update in Internal Medicine December 4, 2016 Fadi Badlissi, MD, MSc Director of the Musculoskeletal Medicine Unit The Orthopedic Department & Rheumatology Division Beth Israel Deaconess Medical Center
More informationMUSCULOSKELETAL PHARMACOLOGY. A story of the inflamed
MUSCULOSKELETAL PHARMACOLOGY A story of the inflamed 1 INFLAMMATION Pathophysiology Inflammation Reaction to tissue injury Caused by release of chemical mediators Leads to a vascular response Fluid and
More informationTherapy for Gout: The Past
Advances in Therapy for Gout: 2011 The Past, Present, and Future Therapy for Gout: The Past May 22, 1997 Pity a Tyrannosaur? Sue Had Gout By MALCOLM W. BROWNE Jonathan Graf, M.D. Associate Professor of
More informationUloric Step Therapy Program
Uloric Step Therapy Program Policy Number: 5.01.584 Last Review: 7/2017 Origination: 7/2014 Next Review: 7/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for brand
More informationGout. Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 CLINICAL REVIEW
Gout Edward Roddy, 1 Christian D Mallen, 1 Michael Doherty 2 1 Arthritis Research UK Primary Care Centre, Primary Care Sciences, Keele University, Keele ST5 5BG, UK 2 Academic Rheumatology, University
More informationImplementing AHRQ Effective Health Care Reviews Helping Clinicians Make Better Treatment Choices
Implementing AHRQ Effective Health Care Reviews Helping Clinicians Make Better Treatment Choices Gout: Diagnosis and Management Practice Pointers by MATTHEW R. NOSS, DO, MSEd, U.S. Army Health Clinic,
More informationGOUT GO FOR SIX WITH. Everything You Need to Know about Gout & Uric Acid PLUS:
GO FOR SIX WITH Everything You Need to Know about Gout & Uric Acid GOUT PLUS: How to gain control of symptoms A gout-friendly eating style Medication recommendations to discuss with your doctor Lifestyle
More informationD espite reasonable understanding of its pathogenesis
1312 EXTENDED REPORT EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics
More informationCopyright 2016 Wolters Kluwer Health, Inc. All rights reserved.
14 The Nurse Practitioner Vol. 41, No. 14 www.tnpj.com 2.5 CONTACT HOURS 2.5 CONTACT HOURS Gout An update on for primary care providers Abstract: This article discusses the current beliefs regarding the
More informationBY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Definition and Risk Factors Idiopathic vs. Secondary OA Clinical Features Diagnosis Radiologic Features ACR OA
More informationZurampic. (lesinurad) New Product Slideshow
Zurampic (lesinurad) New Product Slideshow Introduction Brand name: Zurampic Generic name: Lesinurad Pharmacological class: URAT1 inhibitor Strength and Formulation: 200mg; tablets Manufacturer: Ironwood
More informationA case of extensive synovial involvement by tophaceous gout
A case of extensive synovial involvement by tophaceous gout Nausheen Khan, MB BS, FCRad (D) Irma van de Werke, MB ChB, FRCR Farzanah Ismail, MB ChB, FCRad (D) Department of Radiology, Kalafong Hospital,
More informationGOUT disease spectrum including
GOUT disease spectrum including *hyperuricemia, *recurrent attacks of acute arthritis associated with monosodium urate crystals in leukocytes found in synovial fluid, *deposits of monosodium urate crystals
More informationOsteoarthritis. Rheumatology Update. Gout 1/17/2013
Osteoarthritis Rheumatology Update Richard Zweig, MD January, 2013 Degeneration of cartilage over time accompanied by increase in bone density and bone formation around the joint Risks include: aging,
More information395: Gout and Other Crystal-Associated Arthropathies
Harrison's Principles of Internal Medicine, 19e > 395: Gout and Other Crystal-Associated Arthropathies H. Ralph Schumacher; Lan X. Chen INTRODUCTION The use of polarizing light microscopy during synovial
More informationGout is a disease resulting from the deposition of monosodium urate crystals in. Diagnosis and Management of Gout. 1 of 7 09/04/22 12:11.
Advertisement Home Page > News & Publications > Journals > American Family Physician > Vol. 59/No. 7 (April 1, 1999) Remember Me Log-in Help Advanced Search Diagnosis and Management of Gout JOEL R. PITTMAN,
More informationSpondyloarthritis: A Gouty Display
Spondyloarthritis: A Gouty Display Preetam Gongidi 1*, Shawn Gough-Fibkins 2 1. Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale, FL, USA 2. Broward General Medical Center,
More informationRheumatology Updates for the Primary Care Provider
Rheumatology Updates for the Primary Care Provider Jean Tayar, MD, RhMSUS Associate Professor Section of Rheumatology and Clinical Immunology Department of General Internal Medicine UT MD Anderson Cancer
More informationRheumatologic Emergencies It s not just swollen joints. Joanne Homik Rheumatologist University of Alberta
Rheumatologic Emergencies It s not just swollen joints Joanne Homik Rheumatologist University of Alberta Or is it? Disclosures No relevant conflicts of interest regarding the content of this presentation
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other PEGLOTICASE KRYSTEXXA 37154 GUIDELINES FOR USE 1. Does the patient have a diagnosis of symptomatic chronic gout (prior to initiating Krystexxa therapy) with clinical
More informationRheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.
Rheumatology Review Update in Internal Medicine Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center Boston MA Case #1 True statement(s) regarding etanercept and leflunomide, for the treatment
More informationTofacitinib ( Xeljanz) Marshall Porter & Lauren Ysais
Tofacitinib ( Xeljanz) Marshall Porter & Lauren Ysais Learning Objectives to Take with You A small molecule Janus Kinase (JAK) Inhibitor treatment for moderate to severe rheumatoid arthritis (RA) reduces
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 24 June 2009 ADENURIC 80 mg, film-coated tablets B/28 (CIP code: 385 724-4) B/84 (CIP code: 572 820-3) ADENURIC 120
More informationCurrent treatment options for acute and chronic gout
DRUG REVIEW n Current treatment options for acute and chronic gout Kelsey Jordan FRCP and Andrew Jeffries PGDip, MRCP Gout is the only curable form of arthritis, yet only a third of patients with chronic
More information2.0. Copyright 2015 Wolters Kluwer Health, Inc. All rights reserved. 24 The Nurse Practitioner Vol. 40, No. 8
2.0 CONTACT HOURS 24 The Nurse Practitioner Vol. 40, No. 8 www.tnpj.com Treatment and gout prevention of o leva Abstract: Gout is a disorder of purine metabolism that primarily occurs in adult males. Elevated
More informationFor more information about how to cite these materials visit
Author(s): Mark McQuillan, M.D., F.A.C.P., F.H.M., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Non-Commercial 3.0 License:
More informationCoverage Criteria: Express Scripts, Inc. monograph dated 12/15/ months or as otherwise noted by indication
BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Kineret (anakinra subcutaneous injection) Commercial HMO/PPO/CDHP
More informationNew Drug Evaluation: lesinurad tablet, oral
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationClass Update: Drugs for Gout
Copyright 2012 Oregon State University. ll Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationCase Report Refractory Gout Attack
Case Reports in Medicine Volume 2012, Article ID 657694, 4 pages doi:10.1155/2012/657694 Case Report Refractory Gout Attack Simone Fargetti, Claudia Goldenstein-Schainberg, Andressa Silva Abreu, and Ricardo
More informationPRELIMINARY CRITERIA FOR THE CLASSIFICATION OF THE ACUTE ARTHRITIS OF PRIMARY GOUT
895 PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF THE ACUTE ARTHRITIS OF PRIMARY GOUT STANLEY L. WALLACE, HARRY ROBINSON, ALFONSE T. MASI, JOHN L. DECKER, DANIEL J. McCARTY. and T SAI-FAN Yo The American
More informationCost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout
Cost-effectiveness of lesinurad (Zurampic ) for the treatment of adult patients with gout The NCPE has issued a recommendation regarding the cost-effectiveness of Lesinurad (Zurampic ) in combination with
More informationDrugs for Gout, osteoarthritis and osteoporosis
MMS Pharmacology Lecture 3 Drugs for Gout, osteoarthritis and osteoporosis Dr Sura Al Zoubi Revision Gout The term gout describes a disease spectrum including hyperuricemia, recurrent attacks of acute
More informationGout Goals Are Not Being Achieved!! Strengthening The Provider/Patient Alliance Featuring PEPtools TM JointsAflame
Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance QS Priorities Gout Goals Are ot Being Achieved!! Strengthening The Provider/Patient Alliance Paul P. Doghramji, MD, FAAFP
More informationAcute polyarticular gout
Annals ofthe Rheumatic Diseases, 1983, 42, 117-112 Acute polyarticular gout DONALD A. RADDATZ,* MAREN L. MAHOWALD, AND PAUL J. BILKA From the Department ofinternal Medicine, University ofminnesota Medical
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Krystexxa) Reference Number: CP.PHAR.115 Effective Date: 06.01.13 Last Review Date: 02.19 Line of Business: Commercial, Medicaid Coding Implications Revision Log See Important Reminder
More informationOxford Kidney Unit. Dietary advice for managing gout Information for patients
Oxford Kidney Unit Dietary advice for managing gout Information for patients page 2 This leaflet is for you if you are suffering from gout. It will give you information to help manage your symptoms. What
More informationACR Meeting November, 2012
ACR Meeting November, 212 Arhalofenate is a Novel Dual-Acting Agent with Uricosuric and Anti-Inflammatory Properties Yun-Jung Choi, Vanina Larroca, Annette Lucman, Vic Vicena, Noe Abarca, Tim Rantz, Brian
More information2) An 87 year old female who is 2 weeks post TKR presents with a sore swollen knee. She has a history of atrial fibrillation. Her vital signs are:
EMQ - Rheumatology For each clinical vignette match the correct diagnosis. Reiter s syndrome Pseudogout Septic arthritis Gout Haemarthrosis Traumatic effusion Ankylosing spondylitis Rheumatoid arthritis
More informationRheumatology Red Flags and Emergencies :Workshop DR. MICHAEL STARR DIVISION OF RHEUMATOLOGY MUHC
Rheumatology Red Flags and Emergencies :Workshop DR. MICHAEL STARR DIVISION OF RHEUMATOLOGY MUHC Family Medicine Review Course, November 28th, 2018 Disclosures Amgen Janssen Roche BMS Pfizer UCB Novartis
More informationEssence of the Revised Guideline for the Management of Hyperuricemia and Gout
Research and Reviews Essence of the Revised Guideline for the Management of Hyperuricemia and Gout JMAJ 55(4): 324 329, 2012 Hisashi YAMANAKA,* 1 The Guideline Revising Committee of Japanese Society of
More informationSecondary Gout Associated with Myeloproliferative Diseases* imt. Sinai Hospital
Chapter VI Secondary Gout Associated with Myeloproliferative Diseases* By TS'AI-FAN Yu, M.D. imt. Sinai Hospital In a variety of disorders of hemopoiesis, the turnover of nucleic acids is greatly augmented,
More informationStudy of Febuxostat for the Management of Hyperuricemia in Gout
Human Journals Review Article October 2015 Vol.:4, Issue:3 All rights are reserved by Sachin S. Shinde et al. Study of Febuxostat for the Management of Hyperuricemia in Gout Keywords: Febuxostat, Hyperuricemia,
More informationClinical Practice Guideline. Gout. Version
Clinical Practice Guideline Gout Version 1.1.2017 August 2017 Table of Contents Introduction...5 Stages of Gout...7 Asymptomatic Hyperuricemia... 7 Acute Intermittent Gout... 7 Advanced Gout... 8 Diagnosis...8
More informationInflammatory rheumatic diseases
Learning objectives Inflammatory rheumatic diseases Bruce Kidd Barts & The London, Queen Mary, University of London To understand: 1. prevalence and range of the rheumatological s 2. clinical features
More informationRETRACTED. 186 Self-Assessment examination
186 Self-Assessment examination inance (in contrast to the classic infantile hemangiomas, which are more common in females). The most common location is the head and neck area, followed by the extremities
More informationThe CKD patient in the office or ER. Dr. Vincent Cheung Nephrologist Peterborough Regional Renal Program November 9 th, 2016
The CKD patient in the office or ER Dr. Vincent Cheung Nephrologist Peterborough Regional Renal Program November 9 th, 2016 Presenter Disclosure Dr. Vincent Cheung Relationships with commercial interests
More information